<DOC>
	<DOCNO>NCT00308750</DOCNO>
	<brief_summary>The purpose study determine : The safety enzastaurin plus pemetrexed carboplatin , pemetrexed carboplatin , docetaxel carboplatin side effect might associate combination drug . Whether combination enzastaurin plus pemetrexed carboplatin pemetrexed carboplatin help patient non-small cell lung cancer live longer , compare combination docetaxel carboplatin . Whether combination enzastaurin plus pemetrexed carboplatin pemetrexed carboplatin make tumor small disappear , long , compare combination docetaxel carboplatin . The effect enzastaurin plus pemetrexed carboplatin , pemetrexed carboplatin docetaxel carboplatin disease relate symptom . The relation smoke history hormone replacement therapy ( woman ) may lung cancer treatment result . The effect certain gene protein sample blood tumor tissue order learn non-small cell lung cancer enzastaurin work body .</brief_summary>
	<brief_title>First Line Chemotherapy Treatment Advanced NSCLC</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>You must diagnose nonsmall cell lung cancer . You must able visit doctor 's office weekly active treatment period need study followup period . You must willing able swallow capsule . Your entry labs medical test must meet study requirement . You must willing blood sample draw tissue sample obtain gene protein test . You receive radiation within 2 week study enrollment . You previously receive anticancer drug therapy nonsmall cell lung cancer . You active infection serious condition . You take aspirin aspirinlike medication regularly able stop take day cycle chemotherapy . You recently lose significant amount weight .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>